Dechert, Sullivan Steer CVS To $2.1B Infusion Biz Buy

Law360, New York (November 27, 2013, 11:13 AM EST) -- Drugstore chain CVS Caremark Corp. will put up $2.1 billion for the private equity-backed infusion unit of Apria Healthcare Group Inc. in a move that will help flesh out its specialty pharmacy offerings and drive new growth, CVS said Wednesday.

Rhode Island-based CVS did not give a financing breakdown for the transaction or sketch out the deal's terms. The acquisition will add roughly $1.4 billion in revenues in the first year after the deal closes, expected in the first quarter of 2014 pending regulatory approval, the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.